David Zaccardelli, CEO of Verona Pharma PLC, recently sold 600,000 shares of the company, bringing his total ownership to 15,250,704 shares. The company focuses on respiratory disease therapies.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing